COVID-19 vaccination in India: we need equity

  Just a few days after starting its own COVID-19 vaccination program , India provided vaccines as grant- in-aid to other countries1 . This was in sharp contrast to some high-income countries which stockpile vaccines,  and block proposals to suspend intellectual property rights in World Trade Organisation2. India now is in the midst of a […]

Read More…

How the World Trade Organization could facilitate access to COVID-19 health technologies?

Governments have faced difficult decisions over the past months, but the decision to remove unnecessary barriers to accessing COVID-19 health technologies like vaccines, diagnostics and treatments should be an obvious one. This decision is currently under debate among member states of the World Trade Organization, who are considering a proposal to waive global intellectual property […]

Read More…

Providing primary care in COVID-19 lockdown to rural, underserved areas of Rajasthan, India

  The first case of SARS-COV-2 was reported in India in 30th January 2020.  A few months down the line, the Government of India announced a sudden lockdown on  24th March. Following the lockdown, all local transport, private and public, came to a halt, private healthcare providers closed their clinics, and government health facilities significantly […]

Read More…

Implementation research for advancing action against non-communicable diseases

The failure to translate health and medical research into policy and services action is well-documented  (1). Human behaviour is complex, and results from trials in controlled settings often do not translate into real life settings (2).  Knowing how best to deliver proven life–saving interventions for the management of non-communicable diseases (NCDs), within existing health systems, […]

Read More…

What does data privacy and its commercialisation mean for global health?

In the world where digital health is becoming the norm – what does data privacy and commercialisation mean for global health ? writes Michael Johnson Imagine you are an activist working to fight corruption within your own government. For ten years you have been receiving regular HIV treatment, but your HIV status is known only […]

Read More…

Why we need to talk about NCDs in children ?

Recent years have seen a notable shift in the field of Global Health. Whereas attention used to focus on the prevention, management and control of the ‘big three’ infectious diseases – HIV, tuberculosis and malaria – the Sustainable Development Goals and WHO’s  Global Action Plan mark the beginning of a new era. This puts welcome […]

Read More…

The Acronyms that Divide Us

TLAs that every HCW Should Know to Better Understand the UNGA HLM on UHC and SDGs writes Alexander W. Peters . The Chair of Medicine (CoM) at a leading hospital cut me off mid-sentence, and I briefly lost my train of thought.  “What are NCDs?” he asked.  We had been discussing, in broad terms, how […]

Read More…

Do we really need more skilled health workers?

Do we really need more skilled health workers in a world of Artificial Intelligence and digital health ? Discusses Kenneth Yakubu  As at 2013, the world was in need of 7.2 million health workers and this shortage is projected to increase to 12.9 million by 2035. This number captures only the need for skilled health […]

Read More…

Our experience with rapid evidence synthesis: mid-level health providers (MLHPs) for Primary Health Care

  What does conducting rapid evidence synthesis for decision making look like? Sandeep Moola shares his experience for developing one on MLHPs for LMICs Historically, mid-level health providers (MLHPs) have been providing diagnostic and clinical services, in high-income countries (HICs) as well as resourced constrained settings in low- and middle-income countries (LMICs). They are variously […]

Read More…